EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Clinerion and Pangaea partner to improve cancer patient lives

Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Pangaea, a machine learning company, pa...
Continue Reading →
Europe

How will Sanofi save €2B? Chopping support staff and ‘smart’ purchasing, for 2

Like many a corporate rejuvenation plan, CEO Paul Hudson's blueprint for Sanofi includes some hefty cost cutting. The French drugmaker's aiming for €2 billion in a...
Continue Reading →
Europe

Clinerion becomes EHDEN certified, supporting the building of a federated health data network in Europe

Basel, Switzerland, December 12th, 2019. Clinerion becomes EHDEN certified, supporting the building of a federated health data network in Europe. ꟷ &nb...
Continue Reading →
Europe

Is $9.7B too big a price for The Medicines Company? Novartis itself seems to think so…

When Novartis unveiled its $9.7 billion buyout of The Medicines Company a few days ago, several analysts suggested the price was too high. Turns out, the Swiss drugm...
Continue Reading →
Europe

Pfizer to debut podcast series around vaccines, probing scientific, cultural and political issues

Pfizer’s latest podcast is a documentary-style dive into vaccines. The eight-part series, called “The Antigen,” launches in mid-December and tackles the scientific, ...
Continue Reading →
Europe

SABCS: Roche’s Perjeta builds case as add-on to Herceptin with new analysis

SAN ANTONIO—Roche is in the hot seat as its longtime breast cancer blockbuster Herceptin faces a growing stable of biosimilar challengers. But other drugs in Roche's...
Continue Reading →
Europe

Novo Nordisk joins UNICEF in global and local efforts to end childhood obesity

Novo Nordisk has joined UNICEF in a new three-year collaborative initiative to end childhood obesity. The partners plan to do global researc...
Continue Reading →
Europe

Over half the nation ‘at risk’ of chronic disease due to obesity

A new NHS report has detailed how more than 56% of adults are at increased, high or very high risk of chronic disease due to their waist circumference and BMI, with ...
Continue Reading →
Europe

Lynparza shows benefits in prostate cancer

Lynparza (olaparib) continues to go from strength to strength, as the MSD and AstraZeneca PARP inhibitor has now been shown to slow or stop tumour growth in some men...
Continue Reading →
Europe

Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D

 Hypha Discovery Limited, a leading specialist CRO, has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug m...
Continue Reading →
Quotient